Skip to main content
TipRanks
Go Ultimate75% OFF

Phunware (2RJA) AI Stock Analysis

12 Followers
DE:2RJA

Phunware

(Frankfurt:2RJA)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Low LeverageVery low debt reduces fixed financial obligations and preserves flexibility to fund operations or strategic initiatives without heavy interest burdens. The sizable equity base also provides a stronger capital cushion, although continued losses could weaken that support over time.
Negative Factors
Severe UnprofitabilityLosses remain exceptionally large relative to revenue, showing that the current operating model has not reached sustainable profitability. Deep operating losses can consume capital, limit reinvestment capacity and make the success of the repositioning important to longer-term financial stability.

Phunware (2RJA) vs. iShares MSCI Germany ETF (EWG)

-40%-30%-20%-10%0%10%20%DE:2RJA-19.74%EWG+6.38%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 36.60M
Dividend Yield
―
Average Volume (3M)
667
Price to Earnings (P/E)
-2.7
Beta (1Y)
0.79
Revenue Growth
6.51%
EPS Growth
17.05%
Country
Germany
Employees
26
Sector
Technology
Sector Strength
61
Industry
Software - Application

Phunware Business Overview & Revenue Model

Company Description

Phunware, Inc., operating alongside its subsidiaries, delivers an integrated software platform designed to empower companies globally and within the United States. Its primary aim is to provide clients with the tools, solutions, and services needed t...

Phunware Earnings Call Summary

Earnings Call Date:Nov 07, 2024(Q3-2024)|% Change Since:-74.33%|Next Earnings Date:Nov 05, 2026
Earnings Call SentimentNeutral

The earnings call highlighted significant improvements in bookings, gross margin, and a substantial increase in cash reserves while maintaining a debt-free status. However, there was a decline in net revenues and a continuing non-GAAP adjusted EBITDA loss. Overall, while there are positive strides in financial health and strategic positioning, the decline in revenues indicates challenges that need addressing.

Positive Updates

Significant Increase in Software Subscriptions and Service Bookings
Year-to-date software subscriptions and service bookings for the 9 months ended September 30 increased nearly 300% to $2.2 million in 2024 compared to $600,000 in 2023.

Negative Updates

Decline in Net Revenues
Net revenues for Q3 2024 were approximately $665,000, down from $1.3 million in Q3 2023. Year-to-date net revenues also decreased from $3.9 million in 2023 to $2.6 million in 2024.

Company Guidance

During the Phunware Q3 2024 earnings call, the company provided comprehensive guidance on its strategic direction and financial performance. Phunware's year-to-date software subscriptions and service bookings increased by nearly 300% to $2.2 million compared to $600,000 in 2023. The company's gross margin also improved to 51% in 2024 from 32% in 2023. Operating expenses decreased by 28% in Q3 2024 compared to Q3 2023, excluding a goodwill impairment expense in the previous year. The non-GAAP adjusted EBITDA loss was approximately $2.9 million for Q3 2024, showing a significant improvement from a $3.3 million loss in the same quarter of 2023. Phunware ended the quarter with $35.6 million in cash and no debt, bolstered by its at-the-market equity program, which raised gross proceeds of $16.8 million. Subsequent to the quarter, the company raised an additional $79.8 million, bringing its cash reserves to approximately $100 million. This strong financial position supports Phunware's strategic focus on integrating AI into mobile solutions and targeting enterprise and federal government contracts, with expectations to launch a next-generation AI-driven SaaS platform by mid-2025.

Phunware Risk Analysis

Phunware disclosed 67 risk factors in its most recent earnings report. Phunware reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

1 New Risk
1.Activist investors could cause us to incur substantial costs, divert management's attention and cause a disruption to or uncertainty about the strategic direction of our business.Q2, 2026

Phunware Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:2RJA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
NTWKNTWK70Outperform$83.67M27.467.84%―12.53%-0.08%
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%
AWREAWRE44Neutral$19.43M-2.48-36.87%―-9.81%-45.08%
SURGSURG44Neutral$9.82M-0.10193.81%―83.91%38.02%
BMRBMR42Neutral$14.98M-2.09-52.77%―-7.06%-58.16%

* Technology Sector Average

Performance Comparison

-100%0%100%DE:2RJAAWRENTWKSURGAMODBMRDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:2RJA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:2RJAPhunware1.52-0.41-21.19%
AWREAware Inc.0.95-1.40-59.49%
NTWKNetsol6.894.06143.46%
SURGSurgepays Inc0.15-1.86-92.57%
AMODAlpha Modus Holdings, Inc.0.95-37.85-97.55%
BMRBeamr Imaging Ltd.0.96-1.10-53.35%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.